Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

ABSTRACT: We aimed to evaluate changes in expression in control and th1/th1 mice treated with PBS and apo-transferrin to understand the effect(s) of exogenous apo-transferrin on normal and ineffective erythropoiesis

ORGANISM(S): Mus musculus

PROVIDER: GSE158839 | GEO | 2020/10/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

Project description:Effect of exogenous apo-transferrin on erythropoiesis in Hbbth-1 (th1/th1) mice, a model of beta-thalassemia intermedia

| PRJNA666678 | ENA

Human holo-transferrin glycation

Project description:Understanding the effect of glycation on the function of transferrin, the systemic iron transporter, is fundamental to fully grasp the mechanisms leading to the loss of iron homeostasis observed in diabetes mellitus (DM). The spontaneous reaction with protein amino groups is one of the main causes of glucose toxicity, but the site specificity of this reaction is still poorly understood. Unbalance of iron metabolism has long been described in DM patients, and one of the main features is the occurrence of non-transferrin-bound iron in the blood serum. The presence of these toxic iron species is observed, despite low transferrin saturation levels. Here in, an in vitro approach was used to study human holo-transferrin glycation in detail. Holo-transferrin was incubated with increasing concentration of glucose (10; 20; 100 and 500 mM) and glycation sites were identified using nano-reverse phase – liquid chromatography coupled to high resolution mass spectrometry (nLC-MS). Overall 21 glycation hotspots were identified with lysine residues 103, 312 and 380 proving to be the most reactive sites. Glycation specificity was found to be remarkably different from that described for apo-transferrin.

2018-05-30 | PXD009345 | Pride

Tindallia californiensis strain:APO

Project description:Tindallia californiensis APO genome sequencing

| PRJNA323219 | ENA

Lp(a) and 17K recombinant apo(a) treatment of THP-1 macrophages

Project description:Lp(a) and its distinguishing apolipoprotein constituent apo(a) have been shown to elicit proinflammatory responses from monocytes and macrophages. To obtain a global picture of the effect of Lp(a) and apo(a) on the transcriptome of these cells, we treated THP-1 macrophages with 250 nM Lp(a) or apo(a) for 6 hours, harvested RNA from the cells, and then performed RNA-seq using an Illumina NextSeq instrument. Analysis of the data using GO and KEGG strategies revealed a series of proinflammatory genes upregulated by apo(a) and even more dramatically by Lp(a).

2023-05-08 | GSE226759 | GEO

Oryza sativa cultivar:IR64 and Apo

Project description:Oryza sativa cultivar:IR64 and Apo Raw sequence reads

| PRJNA679128 | ENA

Transcriptomic analysis of transferrin protective effect during retinal detachment in mice

Project description:Transcriptomic analysis of transferrin protective effect during retinal detachment in mice.

2019-08-31 | GSE102824 | GEO

A pilot study of subcutaneous decitabine in ?-thalassemia intermedia.

Project description: Not available

| S-EPMC3172790 | biostudies-literature

Impact of Acute methionine restriction on proteome of Th1 cells - Part 2

Project description:CD4 T cells were activated using CD3/CD28 antibodies in the presence of IL2 and IL12, to generate Th1 cells. Th1 cells were maintained and expanded in IL2 and IL12, on D5 Th1 cells were sorted for CD4+ expression and DAP1 exclusion. After flow sorting, live TH1 cells were resuspended (1e6 per ml) in methionine free RPMI, supplemented with 10% dialysed FBS, IL2 and IL12, and with L-methionine (100μM, or 1μM). Cells were cultured for 5 hrs before collection for proteomics processing.

2019-03-29 | PXD012053 | Pride

P2X7 signaling drives Th1 cell differentiation through metabolic reprogramming for aerobic glycolysis

Project description:This study provides evidence on the molecular mechanisms by which P2RX7 signaling promotes Th1 cell differentiation. P2RX7 induces T-bet expression and aerobic glycolysis in splenic CD4+ T cells that respond to malaria, at a time prior to Th1/Tfh polarization. Cell-intrinsic P2RX7 signaling sustains the glycolytic pathway and causes bioenergetic mitochondrial stress in activated CD4+ T cells. We also show in vitro the phenotypic similarities of Th1-polarized CD4+ T cells that do not express P2RX7 and those in which the glycolytic pathway is pharmacologically inhibited. In addition, ATP synthase blockade in vitro and the consequent inhibition of oxidative phosphorylation, which forces cells to use aerobic glycolysis, is sufficient to promote rapid CD4+ T cell proliferation and polarization to the Th1 profile in the absence of P2RX7. These data demonstrate that P2RX7-mediated metabolic reprograming for aerobic glycolysis is a key event for Th1 cell differentiation and suggest that ATP synthase inhibition is a fundamental mechanism by which P2X7 signaling induces the Th1 response.

2023-03-08 | PXD037754 | Pride

Three Mexican Families with ? thalassemia intermedia with different molecular basis.

Project description: Not available

| S-EPMC7198011 | biostudies-literature